KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Gross Profit (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Gross Profit data on record, last reported at $658.1 million in Q4 2025.

  • For Q4 2025, Gross Profit rose 15.33% year-over-year to $658.1 million; the TTM value through Dec 2025 reached $2.7 billion, up 11.8%, while the annual FY2025 figure was $2.7 billion, 11.8% up from the prior year.
  • Gross Profit reached $658.1 million in Q4 2025 per IDXX's latest filing, down from $683.4 million in the prior quarter.
  • Across five years, Gross Profit topped out at $694.7 million in Q2 2025 and bottomed at $456.4 million in Q4 2021.
  • Average Gross Profit over 5 years is $556.1 million, with a median of $545.5 million recorded in 2023.
  • Peak YoY movement for Gross Profit: skyrocketed 30.92% in 2021, then increased 5.05% in 2022.
  • A 5-year view of Gross Profit shows it stood at $456.4 million in 2021, then rose by 6.25% to $484.9 million in 2022, then grew by 8.5% to $526.2 million in 2023, then rose by 8.46% to $570.7 million in 2024, then increased by 15.33% to $658.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Profit were $658.1 million in Q4 2025, $683.4 million in Q3 2025, and $694.7 million in Q2 2025.